Business Wire
January 18, 2024
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) is pleased to announce the results of the voting at its annual general and special meeting of shareholders (the “Shareholders”) held virtually on January 18, 2024 (the “Meeting”).
The company’s management information circular dated December 20, 2023 (the “Circular”), provided in connection with the Meeting listed nine nominees as directors of the Company. We are excited to announce that each of the nine nominees were elected as directors of Organigram.
The successful election of the directors reflects the confidence and support of the shareholders in the leadership of the company. Organigram is committed to upholding the highest standards of corporate governance and looks forward to the continued guidance and insight from its esteemed board of directors.
Organigram is focused on creating innovative products and delivering exceptional experiences for consumers. The company’s dedication to excellence and commitment to quality is evident in its diverse portfolio of cannabis products, including a variety of adult-use recreational cannabis and medical cannabis products. Organigram’s approach to innovation and sustainability sets it apart in the rapidly evolving cannabis industry.
The annual general and special meeting of shareholders was an opportunity to engage with the shareholders and provide insight into the company’s strategic direction and future plans. The company values the input and feedback from its shareholders and is grateful for their ongoing support.
The virtual format of the meeting allowed for effective participation from shareholders and provided a platform for transparency and open communication. Organigram remains dedicated to maintaining strong and meaningful relationships with its shareholders and looks forward to continuing to engage with them on important matters affecting the company.
The successful outcome of the meeting reinforces Organigram’s position as a leading player in the cannabis industry. The company remains committed to driving value for its shareholders and advancing its mission of producing high-quality cannabis products while maintaining a strong commitment to sustainability and corporate responsibility.
As we look ahead, Organigram remains focused on executing its growth strategy and delivering long-term value for its shareholders. The company is dedicated to driving innovation, expanding its product portfolio, and exploring new opportunities that will contribute to its long-term success.
Organigram is grateful for the continued support and confidence of its shareholders, and remains committed to delivering strong results and sustainable growth. The company looks forward to the future with optimism and is excited about the opportunities that lie ahead as it continues to push the boundaries of what is possible in the cannabis industry.
